Pakistan's troubles are increasing day by day due to the steps taken by india after the pahalgam terror attack. The supply of medicines has been disrupted as the indian government suspended trade relations with Pakistan. pakistan has started emergency measures to secure supplies as there is a risk of a shortage of medicines. India's decision to suspend trade relations with pakistan after the pahalgam terror attack is having a serious impact on Pakistan's health system. There is a risk of a drug crisis in pakistan as the supply of medicines and raw materials imported from india has stopped. pakistan on thursday also suspended all trade relations with New delhi after india suspended the Indus Waters Treaty.
 This has resulted in the supply of essential life-saving medicines being cut off. Realizing the gravity of the situation, the Drug Regulatory Authority of pakistan (DRAP) has initiated emergency measures. Although no official notification has been issued yet about the ban on the pharmaceutical sector, the Drug Regulatory Authority of pakistan (DRAP) said it is exploring alternative supply routes from China, Russia, and several european countries as the crisis is likely to erupt. The agency is specifically focusing on bringing in imports of medicines like anti-rabies vaccine, anti-snake venom, cancer therapy, and monoclonal antibodies. While the DRAP preparations are somewhat reassuring, health experts are warning that pakistan could face a serious drug crisis if immediate action is not taken. PPMA appeals to the government Meanwhile, a delegation of the pakistan Pharmaceutical Manufacturers Association (PPMA) met government officials in Islamabad and sought exemption from trade bans for the pharmaceutical sector. PPMA President Tauqir-ul-Haq said that they had stressed in their meetings with officials of DRAP and the Ministry of Commerce that raw materials required for many life-saving medicines are available only from India. The delegation also appealed to the Special Investment Facilities Council (SIFC) to exempt the healthcare sector from the ban to save the lives of patients.

Find out more: